<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25378739</article-id><article-id pub-id-type="pmc">4221762</article-id><article-id pub-id-type="publisher-id">BLT.13.133413</article-id><article-id pub-id-type="doi">10.2471/BLT.13.133413</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Age-specific prevalence of hepatitis&#x000a0;B virus infection in young pregnant women, Hong Kong Special Administrative Region of China</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Pr&#x000e9;valence selon l'&#x000e2;ge de l'infection par le virus de l'h&#x000e9;patite&#x000a0;B chez les femmes enceintes dans la R&#x000e9;gion Administrative sp&#x000e9;ciale de Hong Kong de Chine</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Prevalencia por edad de la infecci&#x000f3;n por el virus de la hepatitis&#x000a0;B en mujeres embarazadas de Hong Kong, Regi&#x000f3;n Administrativa Especial de China</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x00639;&#x0062f;&#x00648;&#x00649; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" &#x0062d;&#x00633;&#x00628; &#x00627;&#x00644;&#x00641;&#x00626;&#x00629; &#x00627;&#x00644;&#x00639;&#x00645;&#x00631;&#x0064a;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00627;&#x00644;&#x0062d;&#x00648;&#x00627;&#x00645;&#x00644; &#x00641;&#x0064a; &#x00645;&#x00646;&#x00637;&#x00642;&#x00629; &#x00647;&#x00648;&#x00646;&#x0063a; &#x00643;&#x00648;&#x00646;&#x0063a; &#x00627;&#x00644;&#x00635;&#x0064a;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00625;&#x0062f;&#x00627;&#x00631;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x09999;&#x06e2f;&#x05b55;&#x05987;&#x07279;&#x05b9a;&#x05e74;&#x09f84;&#x06bb5;&#x04e59;&#x0578b;&#x0809d;&#x0708e;&#x075c5;&#x06bd2;&#x0611f;&#x067d3;&#x06d41;&#x0884c;&#x07387;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00417;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B &#x0043e;&#x00442; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00430; &#x00441;&#x00440;&#x00435;&#x00434;&#x00438; &#x00431;&#x00435;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d; &#x00432; &#x00421;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c; &#x00430;&#x00434;&#x0043c;&#x00438;&#x0043d;&#x00438;&#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x0043c; &#x0043e;&#x0043a;&#x00440;&#x00443;&#x00433;&#x00435; &#x00413;&#x0043e;&#x0043d;&#x0043a;&#x0043e;&#x0043d;&#x00433;, &#x0041a;&#x00438;&#x00442;&#x00430;&#x00439;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Terence T Lao et al.</alt-title><alt-title alt-title-type="title-running-head">Hepatitis&#x000a0;B in pregnant women, Hong Kong SAR, China</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Lao</surname><given-names>Terence T</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sahota</surname><given-names>Daljit S</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Law</surname><given-names>Lai-Wa</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Yvonne KY</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Leung</surname><given-names>Tak-Yeung</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Ngan Shing Street, Shatin, New Territories, Hong Kong Special Administrative Region, <country>China</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Terence T Lao (email: <email xlink:href="lao-tt@cuhk.edu.hk.com">lao-tt@cuhk.edu.hk.com</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>03</day><month>9</month><year>2014</year></pub-date><volume>92</volume><issue>11</issue><fpage>782</fpage><lpage>789</lpage><history><date date-type="received"><day>19</day><month>11</month><year>2013</year></date><date date-type="rev-recd"><day>23</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>08</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>(c) 2014 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access"><license-p> This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. </license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To investigate the age-specific prevalence of hepatitis&#x000a0;B virus (HBV) infection in young pregnant women in Hong Kong Special Administrative Region (SAR), China, and to determine whether an increase in prevalence occurs during adolescence.</p></sec><sec><title>Methods</title><p>HBV prevalence was quantified using data from routine antenatal screening for hepatitis&#x000a0;B surface antigen (HBsAg) in 10&#x02009;808 women aged 25&#x000a0;years or younger born in Hong Kong SAR and managed at a single hospital between 1998 and 2011. The effect on prevalence of maternal age, parity and birth before or after HBV vaccine availability in 1984 was assessed, using Spearman&#x02019;s correlation and multiple logistic regression analysis.</p></sec><sec><title>Findings</title><p>Overall, 7.5% of women were HBsAg-positive. The prevalence ranged from 2.3% to 8.4% in those aged &#x02264;&#x02009;16 and 23 years, respectively. Women born in or after 1984 and those younger than 18 years of age were less likely to be HBsAg-positive (odds ratio, OR: 0.679; 95% confidence interval, CI: 0.578&#x02013;0.797) and (OR: 0.311; 95% CI: 0.160&#x02013;0.604), respectively. For women born before 1984, there was no association between HBsAg carriage and being younger than 18 years of age (OR: 0.60; 95% CI: 0.262&#x02013;1.370) Logistic regression analysis showed that the prevalence of HBsAg carriage was influenced more by the woman being 18&#x000a0;years old or older (adjusted OR, aOR: 2.80; 95% CI: 1.46&#x02013;5.47) than being born before 1984 (aOR: 1.42; 95% CI: 1.21&#x02013;1.67).</p></sec><sec><title>Conclusion</title><p>Immunity to HBV in young pregnant women who had been vaccinated as neonates decreased in late adolescence.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>&#x000c9;tudier la pr&#x000e9;valence selon l'&#x000e2;ge de l'infection par le virus de l'h&#x000e9;patite&#x000a0;B (VHB) chez les jeunes femmes enceintes dans la R&#x000e9;gion administrative sp&#x000e9;ciale (RAS) de Hong Kong de Chine, et d&#x000e9;terminer si une augmentation de la pr&#x000e9;valence a lieu pendant l'adolescence.</p></sec><sec><title>M&#x000e9;thodes</title><p>La pr&#x000e9;valence du VHB a &#x000e9;t&#x000e9; quantifi&#x000e9;e en utilisant les donn&#x000e9;es des d&#x000e9;pistages pr&#x000e9;nataux de routine pour d&#x000e9;tecter l'antig&#x000e8;ne de surface de l'h&#x000e9;patite&#x000a0;B (HBsAG) chez 10&#x000a0;808&#x000a0;femmes &#x000e2;g&#x000e9;es de moins de 25&#x000a0;ans n&#x000e9;es dans la RAS de Hong Kong et suivies dans un seul h&#x000f4;pital entre 1998 et 2011. Les effets sur la pr&#x000e9;valence de l'&#x000e2;ge maternel, de la parit&#x000e9; et de la naissance avant ou apr&#x000e8;s la disponibilit&#x000e9; du vaccin anti-VHB en&#x000a0;1984 ont &#x000e9;t&#x000e9; &#x000e9;valu&#x000e9;s en utilisant la corr&#x000e9;lation de Spearman et une analyse de r&#x000e9;gression logistique multiple.</p></sec><sec><title>R&#x000e9;sultats</title><p>Globalement, 7,5% des femmes &#x000e9;taient positives pour l'antig&#x000e8;ne HBsAg. La pr&#x000e9;valence &#x000e9;tait comprise entre 2,3% et 8,4% chez les femmes &#x000e2;g&#x000e9;es de &#x02264;&#x02009;16 et 23&#x000a0;ans, respectivement. Les femmes n&#x000e9;es en&#x000a0;1984 ou apr&#x000e8;s&#x000a0;1984 et les femmes &#x000e2;g&#x000e9;es de moins de 18&#x000a0;ans &#x000e9;taient moins susceptibles d'&#x000ea;tre positives pour l'antig&#x000e8;ne HBsAg (rapport des cotes, RC: 0,679; intervalle de confiance &#x000e0; 95%, IC&#x000a0;95%: 0,578&#x02013;0,797) et (RC: 0,311; IC&#x000a0;95%: 0,160&#x02013;0,604), respectivement. Pour les femmes n&#x000e9;es avant&#x000a0;1984, il n'y avait pas d'association entre &#x000ea;tre d&#x000e9;pist&#x000e9;e positive pour l'antig&#x000e8;ne HBsAG et avoir moins de 18&#x000a0;ans (RC: 0,60; IC&#x000a0;95%: 0,262&#x02013;1,370). L'analyse de r&#x000e9;gression logistique a montr&#x000e9; que la pr&#x000e9;valence de la pr&#x000e9;sence de l'antig&#x000e8;ne HBsAg chez les femmes &#x000e9;tait davantage influenc&#x000e9;e par le fait d'avoir 18&#x000a0;ans ou plus (RC ajust&#x000e9;, RCa: 2,80; IC&#x000a0;95%: 1,46&#x02013;5,47) que par le fait d'&#x000ea;tre n&#x000e9;e avant&#x000a0;1984 (RCa: 1,42; IC&#x000a0;95%: 1,21&#x02013;1,67).</p></sec><sec><title>Conclusion</title><p>L'immunit&#x000e9; contre le VHB chez les jeunes femmes enceintes qui ont &#x000e9;t&#x000e9; vaccin&#x000e9;es d&#x000e8;s leur naissance a diminu&#x000e9; &#x000e0; la fin de l'adolescence.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Investigar la prevalencia por edad de la infecci&#x000f3;n por el virus de la hepatitis&#x000a0;B (VHB) en mujeres embarazadas j&#x000f3;venes en Hong Kong, Regi&#x000f3;n Administrativa Especial (SAR) de China, y determinar si durante la adolescencia se produce un aumento de la prevalencia.</p></sec><sec><title>M&#x000e9;todos</title><p>La prevalencia del VHB se cuantific&#x000f3; a partir de datos de las pruebas rutinarias de detecci&#x000f3;n prenatal para el ant&#x000ed;geno de superficie del virus de la hepatitis&#x000a0;B (HBsAg) en 10&#x000a0;808 mujeres de 25 a&#x000f1;os o menores nacidas en Hong Kong SAR y gestionados en un solo hospital entre 1998 y 2011. Se evalu&#x000f3; el efecto de la edad de la madre, el n&#x000fa;mero de veces que hab&#x000ed;an dado a luz y el nacimiento antes o despu&#x000e9;s de la disponibilidad de la vacuna del VHB en 1984 sobre la prevalencia. Para ello se emple&#x000f3; la correlaci&#x000f3;n de Spearman y an&#x000e1;lisis de regresi&#x000f3;n log&#x000ed;stica m&#x000fa;ltiple.</p></sec><sec><title>Resultados</title><p>En general, el 7,5% de las mujeres dio resultados positivos para el HBsAg. La prevalencia vari&#x000f3; del 2,3% al 8,4% en las mujeres de 16 a&#x000f1;os o mayores y 23 de a&#x000f1;os o mayores, respectivamente. Las mujeres nacidas en el a&#x000f1;o 1984 o m&#x000e1;s tarde, y las menores de 18 a&#x000f1;os de edad ten&#x000ed;an menos probabilidad de dar positivo para el HBsAg (proporci&#x000f3;n de probabilidad, OR: 0,679; intervalo de confianza del 95%, IC: 0,578&#x02013;0,797) y (OR: 0,311; 95% IC: 0,160&#x02013;0,604), respectivamente. Para las mujeres nacidas antes de 1984, no hubo asociaci&#x000f3;n entre ser portadoras de HBsAg y ser menores de 18 a&#x000f1;os de edad (OR: 0,60; 95% IC: 0,262&#x02013;1,370). El an&#x000e1;lisis de regresi&#x000f3;n log&#x000ed;stica mostr&#x000f3; que la prevalencia de las portadoras de HBsAg se vio m&#x000e1;s influida por tener 18 o m&#x000e1;s a&#x000f1;os de edad (OR ajustada, proporci&#x000f3;n de probabilidades ajustadas: 2,80; 95% IC: 1,46&#x02013;5,47) que por haber nacido antes de 1984 (proporci&#x000f3;n de probabilidades ajustadas: 1,42; 95% IC: 1,21&#x02013;1,67).</p></sec><sec><title>Conclusi&#x000f3;n</title><p>La inmunidad frente al VHB en mujeres j&#x000f3;venes embarazadas que hab&#x000ed;an sido vacunadas como reci&#x000e9;n nacidos disminuy&#x000f3; a finales de la adolescencia.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062a;&#x0062d;&#x00631;&#x0064a; &#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x00639;&#x0062f;&#x00648;&#x00649; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" &#x0062d;&#x00633;&#x00628; &#x00627;&#x00644;&#x00641;&#x00626;&#x00629; &#x00627;&#x00644;&#x00639;&#x00645;&#x00631;&#x0064a;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00627;&#x00644;&#x0062d;&#x00648;&#x00627;&#x00645;&#x00644; &#x00635;&#x0063a;&#x00627;&#x00631; &#x00627;&#x00644;&#x00633;&#x00646; &#x00641;&#x0064a; &#x00645;&#x00646;&#x00637;&#x00642;&#x00629; &#x00647;&#x00648;&#x00646;&#x0063a; &#x00643;&#x00648;&#x00646;&#x0063a; &#x00627;&#x00644;&#x00635;&#x0064a;&#x00646;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00625;&#x0062f;&#x00627;&#x00631;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00648;&#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; &#x00645;&#x00627; &#x00625;&#x00630;&#x00627; &#x00643;&#x00627;&#x00646;&#x0062a; &#x00647;&#x00646;&#x00627;&#x00643; &#x00632;&#x0064a;&#x00627;&#x0062f;&#x00629; &#x00641;&#x0064a; &#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00644;&#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x0062e;&#x00644;&#x00627;&#x00644; &#x00633;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00627;&#x00647;&#x00642;&#x00629;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x0062a;&#x00645; &#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631; &#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00645;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00641;&#x0062d;&#x00635; &#x00627;&#x00644;&#x00631;&#x00648;&#x0062a;&#x0064a;&#x00646;&#x0064a; &#x00627;&#x00644;&#x00633;&#x00627;&#x00628;&#x00642; &#x00644;&#x00644;&#x00648;&#x00644;&#x00627;&#x0062f;&#x00629; &#x00644;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00636;&#x0062f; &#x00627;&#x00644;&#x00633;&#x00637;&#x0062d;&#x0064a; &#x00644;&#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" (HBsAg) &#x00644;&#x0062f;&#x00649; 10808 &#x00627;&#x00645;&#x00631;&#x00623;&#x00629; &#x00641;&#x0064a; &#x00633;&#x00646; 25 &#x00639;&#x00627;&#x00645;&#x00627;&#x0064b; &#x00623;&#x00648; &#x00623;&#x00635;&#x0063a;&#x00631; &#x00645;&#x00645;&#x00646; &#x00648;&#x00644;&#x0062f;&#x00646; &#x00641;&#x0064a; &#x00645;&#x00646;&#x00637;&#x00642;&#x00629; &#x00647;&#x00648;&#x00646;&#x0063a; &#x00643;&#x00648;&#x00646;&#x0063a; &#x00627;&#x00644;&#x00625;&#x0062f;&#x00627;&#x00631;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00648;&#x0062a;&#x00644;&#x00642;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x00628;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c;&#x0064a; &#x00641;&#x0064a; &#x00645;&#x00633;&#x0062a;&#x00634;&#x00641;&#x00649; &#x00648;&#x00627;&#x0062d;&#x0062f; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00646; &#x00639;&#x00627;&#x00645; 1998 &#x00625;&#x00644;&#x00649; &#x00639;&#x00627;&#x00645; 2011. &#x00648;&#x0062a;&#x00645; &#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00627;&#x00644;&#x0062a;&#x00623;&#x0062b;&#x0064a;&#x00631; &#x00639;&#x00644;&#x00649; &#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x00633;&#x00646; &#x00627;&#x00644;&#x00623;&#x00645; &#x00648;&#x00627;&#x00644;&#x0062a;&#x00643;&#x00627;&#x00641;&#x00624; &#x00648;&#x00627;&#x00644;&#x00648;&#x00644;&#x00627;&#x0062f;&#x00629; &#x00642;&#x00628;&#x00644; &#x0062a;&#x00648;&#x00627;&#x00641;&#x00631; &#x00644;&#x00642;&#x00627;&#x0062d; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" &#x00641;&#x0064a; &#x00639;&#x00627;&#x00645; 1984 &#x00623;&#x00648; &#x00628;&#x00639;&#x0062f;&#x00647;&#x0060c; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00633;&#x00628;&#x0064a;&#x00631;&#x00645;&#x00627;&#x00646; &#x00648;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x0062f;&#x00627;&#x0062f; &#x00627;&#x00644;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00633;&#x0062a;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00639;&#x0062f;&#x0062f;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x00628;&#x00634;&#x00643;&#x00644; &#x00639;&#x00627;&#x00645;&#x0060c; &#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; <styled-content style-type="direction" style="direction:ltr;">7.5&#x000a0;% </styled-content>&#x00645;&#x00646; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00627;&#x0062a; &#x00644;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00636;&#x0062f; &#x00627;&#x00644;&#x00633;&#x00637;&#x0062d;&#x0064a; &#x00644;&#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;". &#x00648;&#x0062a;&#x00631;&#x00627;&#x00648;&#x0062d; &#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00644;&#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x00645;&#x00646; <styled-content style-type="direction" style="direction:ltr;">2.3&#x000a0;% </styled-content>&#x00625;&#x00644;&#x00649; <styled-content style-type="direction" style="direction:ltr;">8.4&#x000a0;% </styled-content>&#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00641;&#x0064a; &#x00633;&#x00646; 16 &#x00648;23 &#x00633;&#x00646;&#x00629;&#x0060c; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00627;&#x00644;&#x0064a;. &#x00648;&#x00643;&#x00627;&#x00646;&#x0062a; &#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00636;&#x0062f; &#x00627;&#x00644;&#x00633;&#x00637;&#x0062d;&#x0064a; &#x00644;&#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" &#x00623;&#x00642;&#x00644; &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00627;&#x00644;&#x00644;&#x00627;&#x0062a;&#x0064a; &#x00648;&#x00644;&#x0062f;&#x00646; &#x00641;&#x0064a; &#x00639;&#x00627;&#x00645; 1984 &#x00623;&#x00648; &#x00628;&#x00639;&#x0062f;&#x00647; &#x00648;&#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x0062f;&#x00648;&#x00646; &#x00633;&#x00646; 18 &#x00633;&#x00646;&#x00629; (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;: 0.679&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 0.578 &#x00625;&#x00644;&#x00649; 0.797) &#x00648;(&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;: 0.311&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>: &#x00645;&#x00646; 0.160 &#x00625;&#x00644;&#x00649; 0.604)&#x0060c; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00627;&#x00644;&#x0064a;. &#x00648;&#x00644;&#x00645; &#x0064a;&#x00643;&#x00646; &#x00647;&#x00646;&#x00627;&#x00643; &#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00646;&#x0062a;&#x00642;&#x00627;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00636;&#x0062f; &#x00627;&#x00644;&#x00633;&#x00637;&#x0062d;&#x0064a; &#x00644;&#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" (HBsAg) &#x00648;&#x00627;&#x00644;&#x00633;&#x00646; &#x00627;&#x00644;&#x00630;&#x0064a; &#x00647;&#x00648; &#x0062f;&#x00648;&#x00646; 18 &#x00633;&#x00646;&#x00629; &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00627;&#x00644;&#x00644;&#x00627;&#x0062a;&#x0064a; &#x00648;&#x00644;&#x0062f;&#x00646; &#x00642;&#x00628;&#x00644; &#x00639;&#x00627;&#x00645; 1984 (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;: 0.60&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>: &#x00645;&#x00646; 0.262 &#x00625;&#x00644;&#x00649; 1.370) &#x00648;&#x00623;&#x00638;&#x00647;&#x00631; &#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x0062f;&#x00627;&#x0062f; &#x00627;&#x00644;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00633;&#x0062a;&#x0064a; &#x0062a;&#x00623;&#x0062b;&#x00631; &#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00646;&#x0062a;&#x00634;&#x00627;&#x00631; &#x00627;&#x00646;&#x0062a;&#x00642;&#x00627;&#x00644; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00636;&#x0062f; &#x00627;&#x00644;&#x00633;&#x00637;&#x0062d;&#x0064a; &#x00644;&#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" (HBsAg) &#x00639;&#x00644;&#x00649; &#x00646;&#x0062d;&#x00648; &#x00623;&#x00643;&#x00628;&#x00631; &#x00628;&#x00633;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00623;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00628;&#x00644;&#x0063a; &#x00645;&#x00646; &#x00627;&#x00644;&#x00639;&#x00645;&#x00631; 18 &#x00633;&#x00646;&#x00629; &#x00623;&#x00648; &#x00623;&#x00643;&#x00628;&#x00631; (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; &#x00627;&#x00644;&#x00645;&#x00635;&#x0062d;&#x0062d;&#x00629;: 2.80&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>: &#x00645;&#x00646; 1.46 &#x00625;&#x00644;&#x00649; 5.47) &#x00639;&#x00646;&#x00647; &#x00628;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00644;&#x00627;&#x0062f; &#x00642;&#x00628;&#x00644; &#x00639;&#x00627;&#x00645; 1984 (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; &#x00627;&#x00644;&#x00645;&#x00635;&#x0062d;&#x0062d;&#x00629;: 1.42&#x0061b; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>: &#x00645;&#x00646; 1.21 &#x00625;&#x00644;&#x00649; 1.67). </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x00627;&#x00646;&#x0062e;&#x00641;&#x00636;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x00629; &#x00636;&#x0062f; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x0062a;&#x00647;&#x00627;&#x00628; &#x00627;&#x00644;&#x00643;&#x00628;&#x0062f; "&#x00628;&#x00627;&#x00621;" &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; &#x00627;&#x00644;&#x0062d;&#x00648;&#x00627;&#x00645;&#x00644; &#x00635;&#x0063a;&#x00627;&#x00631; &#x00627;&#x00644;&#x00633;&#x00646; &#x00627;&#x00644;&#x00644;&#x00627;&#x0062a;&#x0064a; &#x0062d;&#x00635;&#x00644;&#x00646; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00637;&#x00639;&#x0064a;&#x00645; &#x00643;&#x00645;&#x00648;&#x00627;&#x00644;&#x0064a;&#x0062f; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00631;&#x00627;&#x00647;&#x00642;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00623;&#x0062e;&#x00631;&#x00629;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x08c03;&#x067e5;&#x04e2d;&#x056fd;&#x09999;&#x06e2f;&#x07279;&#x0522b;&#x0884c;&#x0653f;&#x0533a;&#x0ff08;SAR&#x0ff09;&#x05e74;&#x08f7b;&#x05b55;&#x05987;&#x07684;&#x07279;&#x05b9a;&#x05e74;&#x09f84;&#x06bb5;&#x04e59;&#x0578b;&#x0809d;&#x0708e;&#x075c5;&#x06bd2;&#x0ff08;HBV&#x0ff09;&#x0611f;&#x067d3;&#x06d41;&#x0884c;&#x07387;&#x0ff0c;&#x05e76;&#x0786e;&#x05b9a;&#x09752;&#x06625;&#x0671f;&#x06d41;&#x0884c;&#x07387;&#x0662f;&#x05426;&#x06709;&#x0589e;&#x052a0;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x04f7f;&#x07528;&#x05728;1998&#x05e74;&#x081f3;2011&#x05e74;&#x05728;&#x05355;&#x06240;&#x0533b;&#x09662;&#x08fdb;&#x0884c;&#x07ba1;&#x07406;&#x07684;10808&#x0540d;25&#x05c81;&#x04ee5;&#x04e0b;&#x07279;&#x0533a;&#x051fa;&#x0751f;&#x05973;&#x06027;&#x07684;&#x04e59;&#x0578b;&#x0809d;&#x0708e;&#x08868;&#x09762;&#x06297;&#x0539f;&#x0ff08;HBsAg&#x0ff09;&#x05e38;&#x089c4;&#x04ea7;&#x0524d;&#x07b5b;&#x067e5;&#x06570;&#x0636e;&#x091cf;&#x05316;HBV&#x06d41;&#x0884c;&#x07387;&#x03002;&#x04f7f;&#x07528;&#x065af;&#x076ae;&#x05c14;&#x066fc;&#x076f8;&#x05173;&#x06027;&#x0548c;&#x0591a;&#x05143;&#x0903b;&#x08f91;&#x056de;&#x05f52;&#x05206;&#x06790;&#x08bc4;&#x04f30;&#x04ea7;&#x05987;&#x05e74;&#x09f84;&#x03001;&#x080ce;&#x06b21;&#x04ee5;&#x053ca;1984&#x05e74;&#x04e59;&#x0578b;&#x0809d;&#x0708e;&#x075c5;&#x06bd2;&#x075ab;&#x082d7;&#x04e0a;&#x05e02;&#x0524d;&#x0540e;&#x051fa;&#x0751f;&#x07b49;&#x056e0;&#x07d20;&#x05bf9;&#x053d1;&#x075c5;&#x07387;&#x07684;&#x05f71;&#x054cd;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x0603b;&#x04f53;&#x0800c;&#x08a00;&#x0ff0c;7.5%&#x05973;&#x06027;&#x04e3a;HBsAg&#x09633;&#x06027;&#x03002;&#x04e0d;&#x08d85;&#x08fc7;16&#x05c81;&#x0548c;&#x04e0d;&#x08d85;&#x08fc7;23&#x05c81;&#x05973;&#x06027;&#x053d1;&#x075c5;&#x07387;&#x05206;&#x0522b;&#x04e3a;2.3%&#x081f3;8.4%&#x03002;&#x05728;1984&#x05e74;&#x06216;&#x04e4b;&#x0540e;&#x051fa;&#x0751f;&#x07684;&#x05973;&#x06027;&#x04ee5;&#x053ca;&#x0672a;&#x06ee1;18&#x05c81;&#x07684;&#x05973;&#x06027;HBsAg&#x09633;&#x06027;&#x053ef;&#x080fd;&#x06027;&#x066f4;&#x04f4e;&#x0ff0c;&#x05206;&#x0522b;&#x04e3a;&#x0ff08;&#x04f18;&#x052bf;&#x06bd4;&#x0ff0c;OR&#x0ff1a;0.679&#x0ff1b;95%&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff0c;CI&#x0ff1a;0.578-0.797&#x0ff09;&#x0548c;&#x0ff08;OR&#x0ff1a;0.311&#x0ff1b;95% CI&#x0ff1a;0.160-0.604&#x0ff09;&#x03002;&#x05bf9;&#x04e8e;&#x05728;1984&#x05e74;&#x04e4b;&#x0524d;&#x051fa;&#x0751f;&#x07684;&#x05973;&#x06027;&#x0ff0c;&#x05728;HBsAg&#x0643a;&#x05e26;&#x0548c;&#x0672a;&#x06ee1;18&#x05c81;&#x0ff08;OR&#x0ff1a;0.60&#x0ff1b;95% CI&#x0ff1a;0.262-1.370&#x0ff09;&#x04e4b;&#x095f4;&#x06ca1;&#x06709;&#x05173;&#x08054;&#x03002;&#x0903b;&#x08f91;&#x056de;&#x05f52;&#x05206;&#x06790;&#x0663e;&#x0793a;&#x0ff0c;&#x08f83;&#x04e4b;1984&#x05e74;&#x04e4b;&#x0524d;&#x051fa;&#x0751f;&#x0ff08;aOR&#x0ff1a;1.42&#x0ff1b;95% CI&#x0ff1a;1.21-1.67&#x0ff09;&#x0ff0c;&#x05973;&#x06027;&#x05e74;&#x06ee1;18&#x05c81;&#x05bf9;HBsAg&#x0643a;&#x05e26;&#x05f71;&#x054cd;&#x066f4;&#x05927;&#x0ff08;&#x08c03;&#x06574;&#x07684;OR&#x0ff0c;aOR&#x0ff1a;2.80&#x0ff1b;95% CI&#x0ff1a;1.46-5.47&#x0ff09;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x05728;&#x065b0;&#x0751f;&#x0513f;&#x0671f;&#x095f4;&#x063a5;&#x079cd;&#x075ab;&#x082d7;&#x07684;&#x05e74;&#x08f7b;&#x05b55;&#x05987;&#x05728;&#x09752;&#x06625;&#x0665a;&#x0671f;&#x04e59;&#x0809d;&#x075c5;&#x06bd2;&#x0514d;&#x075ab;&#x0529b;&#x0964d;&#x04f4e;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x00418;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x00442;&#x0044c; &#x00437;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B (HBV) &#x0043e;&#x00442; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00430; &#x00441;&#x00440;&#x00435;&#x00434;&#x00438; &#x0043c;&#x0043e;&#x0043b;&#x0043e;&#x00434;&#x0044b;&#x00445; &#x00431;&#x00435;&#x00440;&#x00435;&#x0043c;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d; &#x00432; &#x00421;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c; &#x00430;&#x00434;&#x0043c;&#x00438;&#x0043d;&#x00438;&#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x0043c; &#x0043e;&#x0043a;&#x00440;&#x00443;&#x00433;&#x00435; &#x00413;&#x0043e;&#x0043d;&#x0043a;&#x0043e;&#x0043d;&#x00433;, &#x0041a;&#x00438;&#x00442;&#x00430;&#x00439;, &#x00438; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00438;&#x00442;&#x0044c;, &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00430;&#x00435;&#x00442; &#x0043b;&#x00438; &#x00443;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043d;&#x0044c; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x00432; &#x0043f;&#x0043e;&#x00434;&#x00440;&#x0043e;&#x00441;&#x00442;&#x0043a;&#x0043e;&#x00432;&#x0043e;&#x0043c; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00435;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x0041a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x00438; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430;&#x000a0;B (HBV) &#x00431;&#x0044b;&#x0043b;&#x00438; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x0044b; &#x0043d;&#x00430; &#x0043e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x00435; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445;, &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; &#x00445;&#x0043e;&#x00434;&#x00435; &#x0043f;&#x0043b;&#x00430;&#x0043d;&#x0043e;&#x00432;&#x0043e;&#x00433;&#x0043e; &#x0043f;&#x00440;&#x00435;&#x00434;&#x00440;&#x0043e;&#x00434;&#x0043e;&#x00432;&#x0043e;&#x00433;&#x0043e; &#x00441;&#x0043a;&#x00440;&#x00438;&#x0043d;&#x00438;&#x0043d;&#x00433;&#x0043e;&#x00432;&#x0043e;&#x00433;&#x0043e; &#x0043e;&#x00431;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043d;&#x00430; &#x0043d;&#x00430;&#x0043b;&#x00438;&#x00447;&#x00438;&#x00435; &#x0043f;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00445;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00433;&#x00435;&#x0043d;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B (HBsAg) &#x00441;&#x00440;&#x00435;&#x00434;&#x00438; 10&#x000a0;808 &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d; &#x00432; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00435; 25 &#x0043b;&#x00435;&#x00442; &#x00438;&#x0043b;&#x00438; &#x0043c;&#x00435;&#x0043d;&#x00435;&#x00435;, &#x00440;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; &#x00421;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c; &#x00430;&#x00434;&#x0043c;&#x00438;&#x0043d;&#x00438;&#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x0043c; &#x0043e;&#x0043a;&#x00440;&#x00443;&#x00433;&#x00435; &#x00413;&#x0043e;&#x0043d;&#x0043a;&#x0043e;&#x0043d;&#x00433;, &#x0041a;&#x00438;&#x00442;&#x00430;&#x00439;, &#x00441; 1998 &#x0043f;&#x0043e; 2011 &#x00433;&#x00433;. &#x00411;&#x0044b;&#x0043b;&#x00430; &#x00432;&#x0044b;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x00435;&#x0043d;&#x00430; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00430; &#x00432;&#x0043b;&#x00438;&#x0044f;&#x0043d;&#x00438;&#x0044f; &#x0043d;&#x00430; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00442;&#x00430;&#x0043a;&#x00438;&#x00445; &#x00444;&#x00430;&#x0043a;&#x00442;&#x0043e;&#x00440;&#x0043e;&#x00432;, &#x0043a;&#x00430;&#x0043a; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442; &#x0043c;&#x00430;&#x00442;&#x00435;&#x00440;&#x00438;, &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00440;&#x0043e;&#x00434;&#x0043e;&#x00432;, &#x00440;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00434;&#x0043e; &#x00438;&#x0043b;&#x00438; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435; &#x0043f;&#x0043e;&#x0044f;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x0044b; &#x0043e;&#x00442; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B &#x00432; 1984 &#x00433;&#x0043e;&#x00434;&#x00443;; &#x00434;&#x0043b;&#x0044f; &#x00432;&#x0044b;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00438; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438;&#x00441;&#x0044c; &#x0043a;&#x0043e;&#x00440;&#x00440;&#x00435;&#x0043b;&#x0044f;&#x00446;&#x00438;&#x0044f; &#x00421;&#x0043f;&#x00438;&#x00440;&#x0043c;&#x00430;&#x0043d;&#x00430; &#x00438; &#x0043c;&#x0043d;&#x0043e;&#x00433;&#x0043e;&#x00447;&#x00438;&#x00441;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b; &#x00440;&#x00435;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00411;&#x0044b;&#x0043b;&#x0043e; &#x0043e;&#x00431;&#x0043d;&#x00430;&#x00440;&#x00443;&#x00436;&#x00435;&#x0043d;&#x0043e;, &#x00447;&#x00442;&#x0043e; &#x00432; &#x0043e;&#x00431;&#x00449;&#x00435;&#x00439; &#x00441;&#x0043b;&#x0043e;&#x00436;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; 7,5% &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d; &#x0044f;&#x00432;&#x0043b;&#x0044f;&#x0044e;&#x00442;&#x00441;&#x0044f; &#x0043d;&#x0043e;&#x00441;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044f;&#x0043c;&#x00438; &#x0043f;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00445;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00433;&#x00435;&#x0043d;&#x00430; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B. &#x00423;&#x00440;&#x0043e;&#x00432;&#x00435;&#x0043d;&#x0044c; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00432;&#x00430;&#x00440;&#x0044c;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00441;&#x0044f; &#x0043e;&#x00442; 2,3% &#x00434;&#x0043e; 8,4% &#x00432; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x0043d;&#x0044b;&#x00445; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00430;&#x00445; &#x02264;&#x02009;16 &#x0043b;&#x00435;&#x00442; &#x00438; 23 &#x0043b;&#x00435;&#x00442; &#x00441;&#x0043e;&#x0043e;&#x00442;&#x00432;&#x00435;&#x00442;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;. &#x00416;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d;&#x0044b;, &#x00440;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00432; 1984 &#x00433;&#x0043e;&#x00434;&#x00443; &#x00438; &#x0043f;&#x0043e;&#x00437;&#x00434;&#x0043d;&#x00435;&#x00435;, &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d;&#x0044b; &#x0043c;&#x0043b;&#x00430;&#x00434;&#x00448;&#x00435; 18 &#x0043b;&#x00435;&#x00442; &#x00440;&#x00435;&#x00436;&#x00435; &#x0044f;&#x00432;&#x0043b;&#x0044f;&#x0044e;&#x00442;&#x00441;&#x0044f; &#x0043d;&#x0043e;&#x00441;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044f;&#x0043c;&#x00438; &#x0043f;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00445;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00433;&#x00435;&#x0043d;&#x00430; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B (&#x0043a;&#x0043e;&#x0044d;&#x00444;&#x00444;&#x00438;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442; &#x00432;&#x00435;&#x00440;&#x0043e;&#x0044f;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;: 0,679, 95%; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;: 0,578&#x02013;0,797) &#x00438; (&#x0043a;&#x0043e;&#x0044d;&#x00444;&#x00444;&#x00438;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442; &#x00432;&#x00435;&#x00440;&#x0043e;&#x0044f;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;: 0,311, 95%; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;: 0,160&#x02013;0,604) &#x00441;&#x0043e;&#x0043e;&#x00442;&#x00432;&#x00435;&#x00442;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;. &#x00414;&#x0043b;&#x0044f; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d;, &#x00440;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00434;&#x0043e; 1984 &#x00433;&#x0043e;&#x00434;&#x00430;, &#x0043d;&#x00435; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00443;&#x00441;&#x00442;&#x00430;&#x0043d;&#x0043e;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x0043e; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x0043d;&#x00430;&#x0043b;&#x00438;&#x00447;&#x00438;&#x00435;&#x0043c; &#x0043f;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00445;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00433;&#x00435;&#x0043d;&#x00430; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B &#x00438; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x0043e;&#x0043c; &#x0043c;&#x0043b;&#x00430;&#x00434;&#x00448;&#x00435; 18 &#x0043b;&#x00435;&#x00442; (&#x0043a;&#x0043e;&#x0044d;&#x00444;&#x00444;&#x00438;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442; &#x00432;&#x00435;&#x00440;&#x0043e;&#x0044f;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;: 0,60, 95%; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;: 0,262&#x02013;1,370). &#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434; &#x0043b;&#x0043e;&#x00433;&#x00438;&#x00441;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00433;&#x0043e; &#x00440;&#x00435;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00430; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x0043b;, &#x00447;&#x00442;&#x0043e; &#x0043f;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00445;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0043d;&#x0044b;&#x00439; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00433;&#x00435;&#x0043d; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00430; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B &#x00447;&#x00430;&#x00449;&#x00435; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d; &#x00441;&#x00440;&#x00435;&#x00434;&#x00438; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d; 18 &#x0043b;&#x00435;&#x00442; &#x00438; &#x00441;&#x00442;&#x00430;&#x00440;&#x00448;&#x00435; (&#x0043e;&#x00442;&#x0043a;&#x0043e;&#x00440;&#x00440;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00439; &#x0043a;&#x0043e;&#x0044d;&#x00444;&#x00444;&#x00438;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442; &#x00432;&#x00435;&#x00440;&#x0043e;&#x0044f;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;: 2,80, 95%; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;: 1,46&#x02013;5,47), &#x00447;&#x00435;&#x0043c; &#x00441;&#x00440;&#x00435;&#x00434;&#x00438; &#x00440;&#x0043e;&#x00436;&#x00434;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00434;&#x0043e; 1984 &#x00433;&#x0043e;&#x00434;&#x00430; (&#x0043e;&#x00442;&#x0043a;&#x0043e;&#x00440;&#x00440;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00439; &#x0043a;&#x0043e;&#x0044d;&#x00444;&#x00444;&#x00438;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442; &#x00432;&#x00435;&#x00440;&#x0043e;&#x0044f;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;: 1,42, 95%; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;: 1,21&#x02013;1,67).</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00418;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x00438;&#x00442;&#x00435;&#x00442; &#x0043a; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x00443; &#x00433;&#x00435;&#x0043f;&#x00430;&#x00442;&#x00438;&#x00442;&#x00430; B &#x00443; &#x0043c;&#x0043e;&#x0043b;&#x0043e;&#x00434;&#x0044b;&#x00445; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00448;&#x0043b;&#x00438; &#x00432;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0043d;&#x00430;&#x00446;&#x00438;&#x0044e; &#x00432; &#x0043c;&#x0043b;&#x00430;&#x00434;&#x00435;&#x0043d;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x0043c; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442;&#x00435;, &#x00441;&#x0043d;&#x00438;&#x00436;&#x00430;&#x00435;&#x00442;&#x00441;&#x0044f; &#x00432; &#x0043f;&#x0043e;&#x00437;&#x00434;&#x0043d;&#x00435;&#x0043c; &#x0043f;&#x0043e;&#x00434;&#x00440;&#x0043e;&#x00441;&#x00442;&#x0043a;&#x0043e;&#x00432;&#x0043e;&#x0043c; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434;&#x00435;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>It is generally held that vertical transmission is the major route of hepatitis&#x000a0;B virus (HBV) infection in regions where the disease is endemic.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>&#x02013;</sup><xref rid="R5" ref-type="bibr"><sup>5</sup></xref> The neonatal immunization programmes using immunoglobulin and hepatitis&#x000a0;B vaccination that have been developed to prevent vertical transmission<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>&#x02013;</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> have widely been reported to be effective.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref><sup>&#x02013;</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref> Neonatal immunization was introduced to the Hong Kong Special Administrative Region (SAR), China, in 1983<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> and was selectively applied to neonates born to mothers found to be carrying the hepatitis&#x000a0;B surface antigen (HBsAg) on routine antenatal screening.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> In November 1988, neonatal HBV vaccination has become universal irrespective of maternal HBsAg status.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref> Since then, vaccination has been readily available from general practitioners and nongovernmental organizations.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref></p><p>In Hong Kong SAR, pregnant women receiving antenatal care constitute the only social group that undergoes routine HBsAg screening. We reviewed published reports of the prevalence of maternal HBsAg carriage in the area and found that, in the prevaccination era, it was 6.6% in 1976<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> and 7.4% between 1981 and 1983.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> In 1996, it was 10.0% and, between 1998 and 2001, it was 8.0%.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> At our hospital, it was 10.1% in women who gave birth between 1998 and 2008.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> In our latest survey in 2010, the prevalence was 9.1% overall and 4.8% in women who had undergone HBV vaccination.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> Since the obstetric population is a low-risk group compared to those with traditional risk factors for acquiring HBV infection in adulthood, such as intravenous drug users and men who have sex with men, pregnant women can be taken as surrogates for the population at large. Consequently, the 9.0&#x02013;10.0% prevalence of HBsAg carriage observed in these women suggests that Hong Kong SAR remains a high-endemicity area according to the World Health Organization&#x02019;s definition; despite more than two decades of universal neonatal vaccination.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>&#x02013;</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref></p><p>Literature reports suggest that immunity conferred by the vaccine may not always be life-long. One study in Taiwan, China, reported that 1.3% of 2- to 6-year-olds who had undergone complete vaccination were HBsAg-positive,<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> whereas another reported that 1.3&#x02013;3.5% of immunized infants became HBsAg carriers 15&#x000a0;years later.<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> Furthermore, in Alaska, United States of America, a precipitous decline in antibody titre was observed around the age of 15&#x000a0;years in children vaccinated at a very young age<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> and anamnestic responses to booster vaccinations were absent in half of 15-year-olds vaccinated at birth.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Even among fully vaccinated individuals in Taiwan, the seropositivity rate for antibody to HBsAg declined from 100.0% at the age of 2&#x000a0;years to 75.0% at the age of 6&#x000a0;years.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> In addition, 22.9% of vaccinated children in Israel had undetectable antibody levels, irrespective of gestational age, birth weight or parental origin.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> Indeed, it has been recommended that a single booster dose should be given 10&#x000a0;years after primary vaccination because protection was estimated to last between 7.5 and 10.5&#x000a0;years.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></p><p>A recent study in Pakistan found that the HBV infection rate rose from 13.4% among individuals aged 11 to 20&#x000a0;years to 34.9% among those aged 21 to 30&#x000a0;years.<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> We observed recently that the prevalence of HBV infection in university students in Hong Kong SAR, increased with age: it was 0.9%, 2.3%, 4.3% and 5.5% in those aged &#x02264;&#x02009;18, 19, 20 and &#x02265;&#x02009;21&#x000a0;years, respectively.<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> The prevalence also increased with age among women who underwent antenatal screening at our hospital: it was 2.5%, 2.7%, 8.8% and 8.0% in those aged &#x02264;&#x02009;16, 17, 18 and 19&#x000a0;years, respectively.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> These findings suggest that immunity against HBV infection wanes in late adolescence, which could explain the persistently high prevalence of HBsAg carriage we observed in pregnant women. However, the situation in Hong Kong SAR is complicated by the fact that, since the return of sovereignty to China in 1997, there has been a steady influx of immigrants from the mainland, where the prevalence of chronic HBV infection ranged from 4.5% to 17.9% before HBV vaccination was introduced in 1992.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> Consequently, there was a small but steady addition of infected individuals to the pool of fertile women in Hong Kong SAR. Nevertheless, the extent to which these women contributed to the sustained high prevalence of maternal HBV infection in the region remains unclear.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref><sup>&#x02013;</sup><xref rid="R23" ref-type="bibr"><sup>23</sup></xref> We hypothesized that the main reason for the current high prevalence of maternal HBsAg carriage was the progressive waning of vaccine-conferred immunity against HBV infection in late adolescence. Therefore, we re-examined the age-specific prevalence of positive antenatal HBsAg screening test results in pregnant women who had been vaccinated to determine if and when the age-specific prevalence of HBsAg carriage increases during adolescence.</p></sec><sec sec-type="methods"><title>Methods</title><p>Our hospital department is one of the eight public obstetric units in Hong Kong SAR that provide free obstetric care to local residents. We serve a population of 1.2&#x000a0;million, which comprises one seventh of the region&#x02019;s population, and, as the hospital is a tertiary referral centre, we accept referrals from throughout Hong Kong SAR. Our annual delivery rate of 7000 infants is the highest among the eight units. Obstetric management is protocol-driven and includes routine antenatal screening for HBsAg and immunity against rubella, in accordance with official local health policy. The results of investigations and pregnancy outcomes are recorded in a computerized database that covers all public hospitals in Hong Kong SAR. Data entry is performed by trained midwives and obstetricians and is doubled-checked after delivery. To determine whether and when a transition to the current high prevalence of HBV infection occurred during adolescence, we performed a retrospective cohort study of the age-specific prevalence of HBsAg carriage in mothers aged 25&#x000a0;years or younger at delivery who were born in Hong Kong SAR and who were managed between 1998 and 2011. We used data from our obstetric database, which has been previously validated.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> The study was approved by the Joint CUHK-NTEC Clinical Research Ethics Board. </p><p>First, we analysed the age-specific prevalence of HBsAg carriage in the entire group. We investigated the effect on prevalence of the mother&#x02019;s year of birth (i.e. before or in or after 1984, when HBV vaccination became available) and parity (i.e. nulliparity or multiparity) and identified the age at which the transition from a low to a high prevalence occurred. Subsequently, we performed further analyses based on the age of transition identified and, by taking into account the influence of being born before or in or after 1984, we investigated the effect of vaccination on prevalence below and above the age of transition. Statistical analyses were performed using the <italic>&#x003c7;<sup>2</sup></italic> test and odds ratios (ORs) and 95% confidence intervals (CIs) were calculated as appropriate. Correlations between prevalence and age were evaluated using Spearman&#x02019;s correlation coefficient. Multiple logistic regression analysis was used to determine whether the prevalence was significantly influenced by parity, maternal birth before the implementation of HBV immunization or maternal age above or below the age of transition. Calculations were performed using SPSS Statistics 20 (IBM, Armonk, United States of America).</p></sec><sec sec-type="results"><title>Results</title><p>Of the 93&#x02009;306 women who gave birth between 1998 and 2011 at our hospital, 10&#x02009;808 (11.6%) were aged 25&#x000a0;years or younger. The overall prevalence of HBsAg carriage in these young women was 7.5%. As only 129 were aged 16&#x000a0;years or younger, they were grouped together for the analysis. The age-specific prevalence of HBsAg carriage is shown in <xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>. There was a significant difference between age groups (<italic>P</italic>&#x02009;=&#x02009;0.020) and a positive correlation between age and prevalence (<italic>P</italic>&#x02009;=&#x02009;0.006). The age-specific prevalence for women who were born before and in or after 1984 is also shown in <xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref> and in <xref ref-type="table" rid="T1">Table&#x000a0;1</xref>. For those born before 1984, there was no significant difference between age groups (<italic>P</italic>&#x02009;=&#x02009;0.558) and no correlation between age and prevalence (<italic>P</italic>&#x02009;=&#x02009;0.666). For those born in or after 1984, there was a significant difference between age groups (<italic>P</italic>&#x02009;=&#x02009;0.018) and a significant positive correlation with age (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Prevalence of hepatitis&#x000a0;B surface antigen carriage in young pregnant women, by age at parturition and year of birth, Hong Kong Special Administrative Region, China, 1998&#x02013;2011</p></caption><p>HBsAg: hepatitis&#x000a0;B surface antigen. </p><graphic xlink:href="BLT.13.133413-F1"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Carriage of hepatitis&#x000a0;B surface antigen by pregnant women, by age at parturition and year of their birth, Hong Kong Special Administrative Region, China, 1998&#x02013;2011</title></caption><table frame="hsides" rules="groups"><col width="76" span="1"/><col width="82" span="1"/><col width="80" span="1"/><col width="11" span="1"/><col width="73" span="1"/><col width="77" span="1"/><col width="127" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Age at parturition (years)</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">No. of women<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Prevalence of HBsAg carriage in women, no. (%)<hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Likelihood of HBsAg carriage by a woman born in or after 1984, OR&#x000a0;(95% CI)</th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">born in or after 1984<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">born before 1984<sup>a</sup></th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">born in or after 1984<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">born before 1984<sup>a</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x02264;&#x02009;16</td><td valign="top" align="center" rowspan="1" colspan="1">98</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1 (1.0)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">2 (6.5)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.149 (0.013&#x02013;1.708)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">17</td><td valign="top" align="center" rowspan="1" colspan="1">145</td><td valign="top" align="center" rowspan="1" colspan="1">84</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2 (1.4)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">4 (4.8)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.280 (0.050&#x02013;1.561)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">248</td><td valign="top" align="center" rowspan="1" colspan="1">185</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">12 (4.8)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">18 (9.7)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.472 (0.221&#x02013;1.006)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">301</td><td valign="top" align="center" rowspan="1" colspan="1">378</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">17 (5.6)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">27 (7.1)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.778 (0.416&#x02013;1.456)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">406</td><td valign="top" align="center" rowspan="1" colspan="1">498</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">17 (4.2)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">47 (9.4)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.419 (0.237&#x02013;0.742)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">409</td><td valign="top" align="center" rowspan="1" colspan="1">644</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">22 (5.4)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">46 (7.1)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.739 (0.438&#x02013;1.248)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">500</td><td valign="top" align="center" rowspan="1" colspan="1">882</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">28 (5.6)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">82 (9.3)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.579 (0.371&#x02013;0.902)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">546</td><td valign="top" align="center" rowspan="1" colspan="1">1162</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">36 (6.6)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">108 (9.3)</td><td valign="top" align="center" rowspan="1" colspan="1">0.689 (0.466&#x02013;1.019)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">545</td><td valign="top" align="center" rowspan="1" colspan="1">1405</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">39 (7.2)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">116 (8.3)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">0.856 (0.587&#x02013;1.249)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">491</td><td valign="top" align="center" rowspan="1" colspan="1">1850</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">41 (8.4)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">145 (7.8)&#x02009;</td><td valign="top" align="center" rowspan="1" colspan="1">1.071 (0.746&#x02013;1.539)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Total</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>3689</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>7119</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>215 (5.8)&#x02009;</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>595 (8.4)&#x02009;</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0.679 (0.578&#x02013;0.797)</bold></td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; HBsAg: hepatitis&#x000a0;B surface antigen; OR: odds ratio.</p><p><sup>a</sup> Neonatal vaccination against the hepatitis&#x000a0;B virus became available in 1984.</p></table-wrap-foot></table-wrap><p>The most marked increase in prevalence occurred around the age of 18&#x000a0;years in women born both before 1984 and in or after 1984: there was a twofold and a greater than threefold increase between the ages of 17 and 18&#x000a0;years in the two groups, respectively. Therefore, a cut-off age of 18&#x000a0;years was adopted for the analysis of the effect of vaccine availability on the prevalence of HBsAg carriage (<xref ref-type="table" rid="T2">Table&#x000a0;2</xref>). The prevalence was found to be significantly lower in women born in or after 1984 than in those born before 1984: 5.8% versus 8.4%, respectively (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). The figure was significantly lower in women born in or after 1984 among both those aged under 18&#x000a0;years (1.2% versus 5.2% for the two birth year groups, respectively; <italic>P</italic>&#x02009;=&#x02009;0.025) and those aged 18&#x000a0;years or more (6.2% versus 8.4%, respectively; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). However, the difference in prevalence between women aged under 18&#x000a0;years and those aged 18&#x000a0;years or more was significant only for those born in or after 1984 (1.2% versus 6.2%, respectively; <italic>P</italic>&#x02009;=&#x02009;0.002). </p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Influence of being older than 18&#x000a0;years at parturition and being born before 1984 on hepatitis&#x000a0;B surface antigen carriage by pregnant women, Hong Kong Special Administrative Region, China, 1998&#x02013;2011</title></caption><table frame="hsides" rules="groups"><col width="88" span="1"/><col width="120" span="1"/><col width="127" span="1"/><col width="127" span="1"/><col width="144" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Women&#x02019;s year of birth</th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Prevalence of HBsAg carriage (%)<hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Likelihood of HBsAg carriage by a woman aged &#x0003c;&#x02009;18&#x000a0;years at parturition, OR&#x000a0;(95% CI)</th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">All women</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Women aged &#x0003c;&#x02009;18 years at parturition</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Women aged &#x02265;&#x02009;18 years at parturition</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">2.5</td><td valign="top" align="center" rowspan="1" colspan="1">7.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.311 (0.160&#x02013;0.604)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x02265;&#x02009;1984</td><td valign="top" align="center" rowspan="1" colspan="1">5.8</td><td valign="top" align="center" rowspan="1" colspan="1">1.2</td><td valign="top" align="center" rowspan="1" colspan="1">6.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.191 (0.061&#x02013;0.600)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;&#x02009;1984</td><td valign="top" align="center" rowspan="1" colspan="1">8.4</td><td valign="top" align="center" rowspan="1" colspan="1">5.2</td><td valign="top" align="center" rowspan="1" colspan="1">8.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.600 (0.262&#x02013;1.370)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">OR (95% CI)<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.679 (0.578&#x02013;0.797)</td><td valign="top" align="center" rowspan="1" colspan="1">0.227 (0.056&#x02013;0.925)</td><td valign="top" align="center" rowspan="1" colspan="1">0.714 (0.607&#x02013;0.840)</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; HBsAg: hepatitis&#x000a0;B surface antigen; NA: not applicable; OR: odds ratio.</p><p><sup>a</sup> Likelihood of hepatitis&#x000a0;B surface antigen carriage by a woman born in or after 1984, when neonatal vaccination against the hepatitis&#x000a0;B virus became available.</p></table-wrap-foot></table-wrap><p>When the effect of parity was analysed, the only significant difference in prevalence found was between nulliparas born in or after 1984 and those born before 1984: 5.6% versus 8.2%, respectively; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, <xref ref-type="table" rid="T3">Table&#x000a0;3</xref>). There was no significant difference in multiparas between those born before or in or after 1984 and no difference between nulliparas and multiparas in either birth year group.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Influence of parity and being born before 1984 on hepatitis&#x000a0;B surface antigen carriage by pregnant women, Hong Kong Special Administrative Region, China, 1998&#x02013;2011</title></caption><table frame="hsides" rules="groups"><col width="88" span="1"/><col width="120" span="1"/><col width="120" span="1"/><col width="134" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Women&#x02019;s year of birth</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Prevalence of HBsAg carriage (%)<hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Likelihood of HBsAg carriage by a nullipara, OR&#x000a0;(95% CI)</th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Nulliparas</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Multiparas</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">All</td><td valign="top" align="center" rowspan="1" colspan="1">7.3</td><td valign="top" align="center" rowspan="1" colspan="1">8.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.879 (0.743&#x02013;1.038)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x02265;&#x02009;1984</td><td valign="top" align="center" rowspan="1" colspan="1">5.6</td><td valign="top" align="center" rowspan="1" colspan="1">6.7</td><td valign="top" align="center" rowspan="1" colspan="1">0.824 (0.591&#x02013;1.148)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;&#x02009;1984</td><td valign="top" align="center" rowspan="1" colspan="1">8.2</td><td valign="top" align="center" rowspan="1" colspan="1">8.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.923 (0.760&#x02013;1.120)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">OR (95% CI)<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">0.655 (0.553&#x02013;0.799)</td><td valign="top" align="center" rowspan="1" colspan="1">0.745 (0.532&#x02013;1.044)</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; HBsAg: hepatitis&#x000a0;B surface antigen; NA: not applicable; OR: odds ratio.</p><p><sup>a</sup> Likelihood of hepatitis&#x000a0;B surface antigen carriage by a woman born in or after 1984, when neonatal vaccination against the hepatitis&#x000a0;B virus became available.</p></table-wrap-foot></table-wrap><p>The relative effect on the prevalence of HBsAg carriage of the year of the mother&#x02019;s birth and the mother&#x02019;s age at parturition was evaluated by multiple logistic regression analysis, with parity as a confounder. Being aged 18&#x000a0;years or more had a greater effect on prevalence (adjusted OR, aOR: 2.80; 95% CI: 1.46&#x02013;5.47) than being born before 1984 (aOR: 1.42; 95% CI: 1.21&#x02013;1.67). The effect of parity was not significant.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The long-term protection provided by a vaccine can be assessed from the anamnestic response to a booster dose, the infection rate in the vaccinated population, in vitro tests of B- and T-cell activity and seroepidemiological studies. The HBV vaccine is thought to induce life-long immunoprotection<xref rid="R11" ref-type="bibr"><sup>11</sup></xref><sup>,</sup><xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> and the latest review suggests there is no need for a booster dose in immunologically competent persons.<xref rid="R33" ref-type="bibr"><sup>33</sup></xref> This view is supported by data showing that 97.0% of children demonstrated an anamnestic response to a booster dose 10 years after infancy vaccination, even if there was only a protective antibody concentration in 64.0% of the children.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref> Nevertheless, other studies reported that effective protection lasted only 15 to 20 years.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="R26" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref> Even among fully vaccinated children, the seropositivity rate for antibody to HBsAg has been reported to decline.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> In one Israeli study, the proportion of children with an undetectable antibody level varied with the interval between vaccination and testing: it was 36.1%, 20.0% and 14.6% in children aged 5 to 8&#x000a0;years, 2.5 to 5&#x000a0;years and 1 to 2.5&#x000a0;years, respectively.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> The loss of protection appears to spare no ethnic group. In Micronesians vaccinated at birth, 8% showed evidence of past HBV infection 15&#x000a0;years later, although none had a chronic infection.<xref rid="R37" ref-type="bibr"><sup>37</sup></xref> Moreover, only 7.3% of uninfected individuals tested positive for antibody and only 47.9% of the remaining individuals had an anamnestic response. Among Australian Aboriginal adolescents, evidence of an active or past HBV infection was found in 11.0% and 19.0%, respectively, despite complete HBV vaccination in infancy.<xref rid="R38" ref-type="bibr"><sup>38</sup></xref> In Taiwan, vaccine failure, which occurred at a rate of 33.3&#x02013;51.4%, was a major cause of hepatocellular carcinoma: the rate of the disease only declined from 0.54 to 0.20 per 100&#x02009;000 children aged 6 to 14&#x000a0;years from before to after the introduction of the vaccination programme. Paradoxically, the risk of the disease was higher in HBV carrier children born after the vaccination programme (risk ratio: 2.3 to 4.5).<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> Thus, it is questionable whether the HBV vaccine offers long-term protection.</p><p>In our study, we observed an age-related increase in the prevalence of HBV infection in women undergoing routine antenatal screening. Although we could not be absolutely certain all these women had completed a course of HBV vaccination, it is likely they had for the following reasons. In addition to the neonatal vaccination programme in Hong Kong SAR, catch-up vaccination was also given to all school students born before 1983.<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> Moreover, in July 1992 the vaccination programme was extended to cover all children born between January 1986 and November 1988 so that, by the end of the 1990s, all children aged 13&#x000a0;years and younger and residing in Hong Kong SAR, irrespective of place of birth, would have been immunized.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> Finally, a supplemental HBV vaccination programme was launched in the 1998 to 1999 school year for primary&#x000a0;6 students who had not received or completed the three-dose regimen &#x02013; the aim was to protect all children before they became sexually active.<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> Indeed, our data indicate that the vaccine conferred a protective effect because the prevalence of HBV infection detected by antenatal screening was significantly lower in women born in or after 1984 than in those born before 1984. However, the prevalence of HBsAg carriage increased with age even in these protected women. In Hong Kong SAR, the prevalence of HBV infection before the introduction of vaccination was 6.6% in 1976<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> and 7.4% in 1981 to 1983.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Thus, the 6.9% prevalence of HBsAg carriage we observed in 18-year-old pregnant women born in or after 1984 was comparable to the 1976 figure and the 8.0% prevalence we observed in 22-year-old women exceeded the figure for 1981 to 1983. Moreover, the 8.4% prevalence we observed in 23-year-old women was the same as in the locally born, resident, adult population in 1996.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> Consequently, our observation of a substantial infection rate in a vaccinated population, taken together with other similar reports in the literature,<xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="R26" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="R38" ref-type="bibr"><sup>38</sup></xref><sup>,</sup><xref rid="R43" ref-type="bibr"><sup>43</sup></xref> provides compelling evidence that the HBV vaccine does not provide long-term protection.</p><p>Before mass HBV vaccination was introduced, a study found that the rate of HBV infection increased from 1.7% among children aged 3 to 5&#x000a0;years to 4.5% among teenagers aged 17 to 19 years,<xref rid="R44" ref-type="bibr"><sup>44</sup></xref> which suggests that horizontal transmission is important during the transition to adulthood. In addition to transmission through sexual intercourse and high-risk behaviours,<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> such as the sharing of needles among heroin addicts, horizontal HBV transmission can occur within the family and community in high-endemicity areas because HBV is present in body fluids such as saliva and urine.<xref rid="R43" ref-type="bibr"><sup>43</sup></xref><sup>,</sup><xref rid="R46" ref-type="bibr"><sup>46</sup></xref> One study found that 17.5% of offspring were HBsAg-positive if either parent was HBsAg-positive compared with 1.5% if both parents were HBsAg-negative<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> and that the presence of an HBV-infected family member was a risk factor at the individual level. This is important in Asia where eating and living with in-laws after marriage is common. It could be that exposure of individuals with declining immunity to infection was one reason for the increase in the prevalence of HBsAg carriage from 1.9% in adolescents to 4.9% in those aged 20 to&#x000a0;30 years reported in the Republic of Korea<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> and for our earlier observation that the prevalence of HBV infection rose rapidly among teenagers in Hong Kong SAR.<xref rid="R30" ref-type="bibr"><sup>30</sup></xref><sup>,</sup><xref rid="R31" ref-type="bibr"><sup>31</sup></xref></p><p>The logical way to reduce the risk of horizontal transmission to individuals with waning immunity is to give a booster dose of HBV vaccine. However, there is no consensus on the necessity of booster doses after neonatal immunization.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> More than a decade ago it was recommended that 12-year-old children should receive a single booster dose 10&#x000a0;years after primary triple-dose vaccination because protection was estimated to last only 7.5 to 10.5&#x000a0;years.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref> Indeed, one study found that the geometric mean decay in the titre of antibody to HBsAg between the ages of 7 and 16&#x000a0;years in children who did not receive booster doses was 20.0% per year.<xref rid="R47" ref-type="bibr"><sup>47</sup></xref> Moreover, there is growing evidence that the antibody titre declines with age, especially after the age of 15&#x000a0;years.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref><sup>&#x02013;</sup><xref rid="R27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="R47" ref-type="bibr"><sup>47</sup></xref> The latest guidelines of the Steering Committee for the Prevention and Control of Infectious Diseases in Asia recommend a booster dose of HBV vaccine: (i)&#x000a0;10 to 15&#x000a0;years after primary vaccination in Asian populations where the virus is highly endemic and where it is not feasible to monitor antibody levels; (ii)&#x000a0;in immunocompromised patients when the antibody titre falls to below10&#x000a0;mIU/mL; and (iii)&#x000a0;in health-care workers.<xref rid="R48" ref-type="bibr"><sup>48</sup></xref> A booster dose was also suggested for individuals who have a poor response to the vaccine and for high-risk adolescents.<xref rid="R49" ref-type="bibr"><sup>49</sup></xref> Nevertheless, a single booster dose may not be sufficient as it has been reported that 2.7% to 3.3% of children remained antibody-negative after the booster,<xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> probably because it did not induce an immune response in healthy adolescents who had an undetectable antibody titre. Responses can be impaired by factors such as ethnicity and substance use.<xref rid="R49" ref-type="bibr"><sup>49</sup></xref></p><p>There is no consensus on the timing of the first booster dose after neonatal vaccination. Reports of declines in antibody titre and protection 10 to 15&#x000a0;years after childhood vaccination,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>&#x02013;</sup><xref rid="R27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="R47" ref-type="bibr"><sup>47</sup></xref> of a precipitous decline in antibody titre at the age of 15&#x000a0;years<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> and of absent anamnestic responses in half of 15-year-old children vaccinated at birth<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R34" ref-type="bibr"><sup>34</sup></xref> all suggest that the immunoprotection induced by the vaccine cannot be guaranteed beyond 16&#x000a0;years of age. In China, the HBsAg seropositivity rate has been reported to increase from 0.3% in individuals aged 15 to 17&#x000a0;years to 1.4% in those aged 18 to 19&#x000a0;years, eventually reaching 3.0% in those aged 24&#x000a0;years.<xref rid="R50" ref-type="bibr"><sup>50</sup></xref> Overall, the evidence &#x02013; especially our finding that there was a transition to a high prevalence of HBV infection at 18&#x000a0;years of age &#x02013; supports the recommendation that a booster dose should be given to all adolescents aged between 16 and 17&#x000a0;years.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="R47" ref-type="bibr"><sup>47</sup></xref><sup>,</sup><xref rid="R48" ref-type="bibr"><sup>48</sup></xref> At present, neither Hong Kong SAR nor any Asian country recommends or gives a routine booster to all adolescents.</p><p>Although our study population was limited by the fact that our hospital serves only one seventh of the total population of Hong Kong SAR, the district served comprises mostly new towns that have been developed in the past 20&#x000a0;years to accommodate younger people with new families moving from other districts. Consequently, the young pregnant women in our study are likely to be representative of those who live in other districts and, therefore, of the local female population.</p><p>In conclusion, our study found that the prevalence of maternal HBV infection in Hong Kong SAR increased from a low to a high rate around the age of 18&#x000a0;years. Above that age, the prevalence of HBsAg carriage in young mothers who should have been protected by neonatal HBV vaccination returned to that observed in 1976 before the vaccination programme was implemented. Since the pregnant women in our study were not at a high risk of acquiring an HBV infection through horizontal transmission, our findings challenge the view that HBV vaccination confers life-long protection. Future studies should investigate the timing and extent of waning immunity against HBV infection with age, the anamnestic response rate and the most cost-effective way of maintaining immunity in adolescents vaccinated in infancy.</p></sec></body><back><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Wong</surname>
<given-names>VC</given-names></string-name>, <string-name><surname>Ip</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Reesink</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Lelie</surname>
<given-names>PN</given-names></string-name>, <string-name><surname>Reerink-Brongers</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Yeung</surname>
<given-names>CY</given-names></string-name>, <etal>et al.</etal><article-title>Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.</article-title><source>Lancet</source>. <year>1984</year>;<volume>1</volume>(<issue>8383</issue>):<fpage>921</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(84)92388-2</pub-id><pub-id pub-id-type="pmid">6143868</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Beasley</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>LY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Lan</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Roan</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>FY</given-names></string-name>, <etal>et al.</etal><article-title>Prevention of perinatally transmitted hepatitis&#x000a0;B virus infections with hepatitis&#x000a0;B immune globulin and hepatitis&#x000a0;B vaccine.</article-title><source>Lancet</source>. <year>1983</year>;<volume>2</volume>(<issue>8359</issue>):<fpage>1099</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(83)90624-4</pub-id><pub-id pub-id-type="pmid">6138642</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Beasley</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>LY</given-names></string-name>, <string-name><surname>Szmuness</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Stevens</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Hsieh</surname>
<given-names>FJ</given-names></string-name>, <etal>et al.</etal><article-title>HBIG prophylaxis for perinatal HBV infections&#x02013;final report of the Taiwan trial.</article-title><source>Dev Biol Stand</source>. <year>1983</year>;<volume>54</volume>:<fpage>363</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">6360754</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Leung</surname>
<given-names>NW</given-names></string-name>. <article-title>Patterns of viral hepatitis in Hong Kong.</article-title><source>Br J Hosp Med</source>. <year>1997</year>;<volume>58</volume>(<issue>4</issue>):<fpage>166</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9373408</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Stevens</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Beasley</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Tsui</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>WC</given-names></string-name>. <article-title>Vertical transmission of hepatitis&#x000a0;B antigen in Taiwan.</article-title><source>N Engl J Med</source>. <year>1975</year>;<volume>292</volume>(<issue>15</issue>):<fpage>771</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM197504102921503</pub-id><pub-id pub-id-type="pmid">1113797</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Yeoh</surname>
<given-names>EK</given-names></string-name>. <article-title>Hepatitis&#x000a0;B vaccination &#x02013; who should be vaccinated?</article-title><source>J Hong Kong Med Assoc</source>. <year>1987</year>;<volume>39</volume>(<issue>4</issue>):<fpage>208</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Assad</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Francis</surname>
<given-names>A</given-names></string-name>. <article-title>Over a decade of experience with a yeast recombinant hepatitis&#x000a0;B vaccine.</article-title><source>Vaccine</source>. <year>1999</year>;<volume>18</volume>(<issue>1-2</issue>):<fpage>57</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(99)00179-6</pub-id><pub-id pub-id-type="pmid">10501235</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Nair</surname>
<given-names>PV</given-names></string-name>, <string-name><surname>Weissman</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Tong</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Thursby</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Paul</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Henneman</surname>
<given-names>CE</given-names></string-name>. <article-title>Efficacy of hepatitis&#x000a0;B immune globulin in prevention of perinatal transmission of the hepatitis&#x000a0;B virus.</article-title><source>Gastroenterology</source>. <year>1984</year>;<volume>87</volume>(<issue>2</issue>):<fpage>293</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">6376265</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>PI</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>. <article-title>A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis&#x000a0;B vaccines in infants.</article-title><source>Vaccine</source>. <year>1995</year>;<volume>13</volume>(<issue>17</issue>):<fpage>1685</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(95)00108-D</pub-id><pub-id pub-id-type="pmid">8719520</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Brok</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Boxall</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Gluud</surname>
<given-names>C</given-names></string-name>. <article-title>Hepatitis&#x000a0;B immunisation for newborn infants of hepatitis&#x000a0;B surface antigen-positive mothers</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2006</year>; (<issue>2</issue>):<fpage>CD004790</fpage>.<pub-id pub-id-type="pmid">16625613</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Gabbuti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Roman&#x000f2;</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blanc</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Meacci</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Amendola</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mele</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal><article-title>Long-term immunogenicity of hepatitis&#x000a0;B vaccination in a cohort of Italian healthy adolescents.</article-title><source>Vaccine</source>. <year>2007</year>;<volume>25</volume>(<issue>16</issue>):<fpage>3129</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2007.01.045</pub-id><pub-id pub-id-type="pmid">17291637</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Hammitt</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Hennessy</surname>
<given-names>TW</given-names></string-name>, <string-name><surname>Fiore</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Zanis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hummel</surname>
<given-names>KB</given-names></string-name>, <string-name><surname>Dunaway</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal><article-title>Hepatitis&#x000a0;B immunity in children vaccinated with recombinant hepatitis&#x000a0;B vaccine beginning at birth: a follow-up study at 15 years.</article-title><source>Vaccine</source>. <year>2007</year>;<volume>25</volume>(<issue>39-40</issue>):<fpage>6958</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2007.06.059</pub-id><pub-id pub-id-type="pmid">17714836</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Poovorawan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sanpavat</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chumdermpadetsuk</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Safary</surname>
<given-names>A</given-names></string-name>. <article-title>Long-term hepatitis&#x000a0;B vaccine in infants born to hepatitis&#x000a0;B e antigen positive mothers.</article-title><source>Arch Dis Child Fetal Neonatal Ed</source>. <year>1997</year>;<volume>77</volume>(<issue>1</issue>):<fpage>F47</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1136/fn.77.1.F47</pub-id><pub-id pub-id-type="pmid">9279183</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Alfaleh</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Alshehri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alansari</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Aljeffri</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Almazrou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shaffi</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal><article-title>Long-term protection of hepatitis&#x000a0;B vaccine 18 years after vaccination.</article-title><source>J Infect</source>. <year>2008</year>;<volume>57</volume>(<issue>5</issue>):<fpage>404</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2008.08.008</pub-id><pub-id pub-id-type="pmid">18829116</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Liao</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>XJ</given-names></string-name>, <string-name><surname>Gong</surname>
<given-names>J</given-names></string-name>, <etal>et al.</etal><article-title>Long-term efficacy of plasma-derived hepatitis&#x000a0;B vaccine: a 15-year follow-up study among Chinese children.</article-title><source>Vaccine</source>. <year>1999</year>;<volume>17</volume>(<issue>20-21</issue>):<fpage>2661</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(99)00031-6</pub-id><pub-id pub-id-type="pmid">10418916</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Ni</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Chiu</surname>
<given-names>TY</given-names></string-name>, <etal>et al.</etal><article-title>Hepatitis&#x000a0;B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis&#x000a0;B vaccination.</article-title><source>Ann Intern Med</source>. <year>2001</year>;<volume>135</volume>(<issue>9</issue>):<fpage>796</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-135-9-200111060-00009</pub-id><pub-id pub-id-type="pmid">11694104</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Kwan</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Ho</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SS</given-names></string-name>. <article-title>The declining HBsAg carriage rate in pregnant women in Hong Kong.</article-title><source>Epidemiol Infect</source>. <year>1997</year>;<volume>119</volume>(<issue>2</issue>):<fpage>281</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268897007796</pub-id><pub-id pub-id-type="pmid">9363029</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Lok</surname>
<given-names>ASF</given-names></string-name>. <article-title>Hepatitis&#x000a0;B vaccination in Hong Kong.</article-title><source>J Gastroenterol Hepatol</source>. <year>1993</year>;<volume>8</volume>(<issue>S1</issue>):<fpage>S27</fpage>&#x02013;<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1746.1993.tb01677.x</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="web">Surveillance of viral hepatitis in Hong Kong &#x02013; 2006 update report. Hong Kong: Department of Health; 2007. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.info.gov.hk/hepatitis/doc/hepsurv06.pdf">http://www.info.gov.hk/hepatitis/doc/hepsurv06.pdf</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2014 Jul 10].</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Ip</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>VC</given-names></string-name>. <article-title>Mechanisms of maternal&#x02013;fetal transmission of hepatitis&#x000a0;B virus.</article-title><source>J Infect Dis</source>. <year>1978</year>;<volume>138</volume>(<issue>5</issue>):<fpage>668</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/138.5.668</pub-id><pub-id pub-id-type="pmid">712120</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Lao</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>WC</given-names></string-name>, <string-name><surname>Ho</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Tse</surname>
<given-names>KY</given-names></string-name>. <article-title>Maternal hepatitis&#x000a0;B infection and gestational diabetes mellitus.</article-title><source>J Hepatol</source>. <year>2007</year>;<volume>47</volume>(<issue>1</issue>):<fpage>46</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2007.02.014</pub-id><pub-id pub-id-type="pmid">17434231</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Suen</surname>
<given-names>SSH</given-names></string-name>, <string-name><surname>Lao</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Sahota</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Lau</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>TY</given-names></string-name>. <article-title>Implications of the relationship between maternal age and parity with hepatitis&#x000a0;B carrier status in a high endemicity area.</article-title><source>J Viral Hepat</source>. <year>2010</year>;<volume>17</volume>(<issue>5</issue>):<fpage>372</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2893.2009.01195.x</pub-id><pub-id pub-id-type="pmid">19780946</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Chan</surname>
<given-names>OK</given-names></string-name>, <string-name><surname>Lao</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Suen</surname>
<given-names>SSH</given-names></string-name>, <string-name><surname>Lau</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>TY</given-names></string-name>. <article-title>Correlation between maternal hepatitis&#x000a0;B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?</article-title><source>Infection</source>. <year>2011</year>;<volume>39</volume>(<issue>5</issue>):<fpage>419</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-011-0151-3</pub-id><pub-id pub-id-type="pmid">21713427</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YL</given-names></string-name>, <string-name><surname>Ling</surname>
<given-names>UP</given-names></string-name>, <string-name><surname>Changlai</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>CJ</given-names></string-name>. <article-title>Immune status in preschool children born after mass hepatitis&#x000a0;B vaccination program in Taiwan.</article-title><source>Vaccine</source>. <year>1998</year>;<volume>16</volume>(<issue>17</issue>):<fpage>1683</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(98)00050-4</pub-id><pub-id pub-id-type="pmid">9713947</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Lu</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Chiang</surname>
<given-names>BL</given-names></string-name>, <string-name><surname>Chi</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Ni</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>HM</given-names></string-name>, <etal>et al.</etal><article-title>Waning immunity to plasma-derived hepatitis&#x000a0;B vaccine and the need for boosters 15 years after neonatal vaccination.</article-title><source>Hepatology</source>. <year>2004</year>;<volume>40</volume>(<issue>6</issue>):<fpage>1415</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/hep.20490</pub-id><pub-id pub-id-type="pmid">15565627</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>McMahon</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Bruden</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Bulkow</surname>
<given-names>LR</given-names></string-name>, <string-name><surname>Parkinson</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Nainan</surname>
<given-names>O</given-names></string-name>, <etal>et al.</etal><article-title>Antibody levels and protection after hepatitis&#x000a0;B vaccination: results of a 15-year follow-up.</article-title><source>Ann Intern Med</source>. <year>2005</year>;<volume>142</volume>(<issue>5</issue>):<fpage>333</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-142-5-200503010-00008</pub-id><pub-id pub-id-type="pmid">15738452</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Gold</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Somech</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mandel</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Peled</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Reif</surname>
<given-names>S</given-names></string-name>. <article-title>Decreased immune response to hepatitis&#x000a0;B eight years after routine vaccination in Israel.</article-title><source>Acta Paediatr</source>. <year>2003</year>;<volume>92</volume>(<issue>10</issue>):<fpage>1158</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2003.tb02477.x</pub-id><pub-id pub-id-type="pmid">14632331</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Sim&#x000f3; Mi&#x000f1;ana</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gaztambide Ganuza</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fern&#x000e1;ndez Mill&#x000e1;n</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pe&#x000f1;a Fern&#x000e1;ndez</surname>
<given-names>M</given-names></string-name>. <article-title>Hepatitis&#x000a0;B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination.</article-title><source>Vaccine</source>. <year>1996</year>;<volume>14</volume>(<issue>2</issue>):<fpage>103</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/0264-410X(95)00176-2</pub-id><pub-id pub-id-type="pmid">8852404</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Khan</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Shams</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Qureshi</surname>
<given-names>ID</given-names></string-name>, <string-name><surname>Israr</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sarwar</surname>
<given-names>MT</given-names></string-name>, <etal>et al.</etal><article-title>Hepatitis&#x000a0;B virus infection among different sex and age groups in Pakistani Punjab.</article-title><source>Virol J</source>. <year>2011</year>;<volume>8</volume>(<issue>1</issue>):<fpage>225</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-8-225</pub-id><pub-id pub-id-type="pmid">21569532</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Suen</surname>
<given-names>SSH</given-names></string-name>, <string-name><surname>Lao</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>OK</given-names></string-name>, <string-name><surname>Lau</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>TY</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>PKS</given-names></string-name>. <article-title>Relationship between age and prevalence of hepatitis&#x000a0;B infection in first-year university students in Hong Kong.</article-title><source>Infection</source>. <year>2013</year>;<volume>41</volume>(<issue>2</issue>):<fpage>529</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-012-0379-6</pub-id><pub-id pub-id-type="pmid">23233215</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Lao</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Sahota</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Suen</surname>
<given-names>SSH</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>PKS</given-names></string-name>, <string-name><surname>Leung</surname>
<given-names>TY</given-names></string-name>. <article-title>Impact of neonatal hepatitis&#x000a0;B vaccination programme on age-specific prevalence of hepatitis&#x000a0;B infection in teenage mothers in Hong Kong.</article-title><source>Epidemiol Infect</source>. <year>2013</year>;<volume>141</volume>(<issue>10</issue>):<fpage>2131</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268812002701</pub-id><pub-id pub-id-type="pmid">23211684</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Luo</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>B</given-names></string-name>. <article-title>Impact of the implementation of a vaccination strategy on hepatitis&#x000a0;B virus infections in China over a 20-year period.</article-title><source>Int J Infect Dis</source>. <year>2012</year>;<volume>16</volume>(<issue>2</issue>):<fpage>e82</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2011.10.009</pub-id><pub-id pub-id-type="pmid">22178658</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Leuridan</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Van Damme</surname>
<given-names>P</given-names></string-name>. <article-title>Hepatitis&#x000a0;B and the need for a booster dose.</article-title><source>Clin Infect Dis</source>. <year>2011</year>;<volume>53</volume>(<issue>1</issue>):<fpage>68</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1093/cid/cir270</pub-id><pub-id pub-id-type="pmid">21653306</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Zanetti</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Mariano</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Roman&#x000f2;</surname>
<given-names>L</given-names></string-name>, <string-name><surname>D&#x02019;Amelio</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chironna</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Coppola</surname>
<given-names>RC</given-names></string-name>, <etal>et al.</etal>; <collab>Study Group</collab>. <article-title>Long-term immunogenicity of hepatitis&#x000a0;B vaccination and policy for booster: an Italian multicentre study.</article-title><source>Lancet</source>. <year>2005</year>;<volume>366</volume>(<issue>9494</issue>):<fpage>1379</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67568-X</pub-id><pub-id pub-id-type="pmid">16226616</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Su</surname>
<given-names>FH</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Sung</surname>
<given-names>KY</given-names></string-name>, <string-name><surname>Jeng</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>FY</given-names></string-name>. <article-title>Waning-off effect of serum hepatitis&#x000a0;B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan&#x02019;s national hepatitis&#x000a0;B vaccination programme.</article-title><source>J Viral Hepat</source>. <year>2008</year>;<volume>15</volume>(<issue>1</issue>):<fpage>14</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">18088240</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Ni</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Yen</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>You</surname>
<given-names>SL</given-names></string-name>, <etal>et al.</etal><article-title>Two decades of universal hepatitis&#x000a0;B vaccination in Taiwan: impact and implication for future strategies.</article-title><source>Gastroenterology</source>. <year>2007</year>;<volume>132</volume>(<issue>4</issue>):<fpage>1287</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.02.055</pub-id><pub-id pub-id-type="pmid">17433322</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Bialek</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Bower</surname>
<given-names>WA</given-names></string-name>, <string-name><surname>Novak</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Helgenberger</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Auerbach</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>IT</given-names></string-name>, <etal>et al.</etal><article-title>Persistence of protection against hepatitis&#x000a0;B virus infection among adolescents vaccinated with recombinant hepatitis&#x000a0;B vaccine beginning at birth: a 15-year follow-up study.</article-title><source>Pediatr Infect Dis J</source>. <year>2008</year>;<volume>27</volume>(<issue>10</issue>):<fpage>881</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/INF.0b013e31817702ba</pub-id><pub-id pub-id-type="pmid">18756185</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Dent</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Selvey</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Davis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>McDonald</surname>
<given-names>MI</given-names></string-name>. <article-title>Incomplete protection against hepatitis&#x000a0;B among remote Aboriginal adolescents despite full vaccination in infancy.</article-title><source>Commun Dis Intell Q Rep</source>. <year>2010</year>;<volume>34</volume>(<issue>4</issue>):<fpage>435</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21413528</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Kong</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>DC</given-names></string-name>, <etal>et al. </etal><collab>Taiwan Childhood HCC Study Group</collab>. <article-title>Prevention of hepatocellular carcinoma by universal vaccination against hepatitis&#x000a0;B virus: the effect and problems.</article-title><source>Clin Cancer Res</source>. <year>2005</year>;<volume>11</volume>(<issue>21</issue>):<fpage>7953</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-1095</pub-id><pub-id pub-id-type="pmid">16278421</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="book">The Scientific Working Group on Viral Hepatitis Prevention. Recommendations on hepatitis&#x000a0;B vaccination regimens in Hong Kong &#x02013; Consensus of the Scientific Working Group on Viral Hepatitis Prevention. Hong Kong: Department of Health; 1998. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.info.gov.hk/hepatitis/doc/a_hepbreg04.pdf">http://www.info.gov.hk/hepatitis/doc/a_hepbreg04.pdf</ext-link> [cited 2014 Jun 3].</mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>SS</given-names></string-name>. <article-title>Hepatitis&#x000a0;B vaccination programme in Hong Kong.</article-title><source>Public Health Epidemiol Bull</source>. <year>1993</year>;<volume>2</volume>:<fpage>9</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Leung</surname>
<given-names>CW</given-names></string-name>. <article-title>Proceedings of state of Asian children. Immunization.</article-title><source>HK J Paediatr (New Series)</source>. <year>1999</year>;<volume>4</volume>:<fpage>9</fpage>&#x02013;<lpage>62</lpage>.</mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Jeong</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Yim</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Yoon</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Jee</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Bae</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>WC</given-names></string-name>. <article-title>Changes in the intrafamilial transmission of hepatitis&#x000a0;B virus after introduction of a hepatitis&#x000a0;B vaccination programme in Korea.</article-title><source>Epidemiol Infect</source>. <year>2010</year>;<volume>138</volume>(<issue>8</issue>):<fpage>1090</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268809991324</pub-id><pub-id pub-id-type="pmid">19951454</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Stroffolini</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Chiaramonte</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Crax&#x000ec;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Franco</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Rapicetta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Trivello</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal><article-title>Baseline sero-epidemiology of hepatitis&#x000a0;B virus infection in children and teenagers in Italy. A survey before mass hepatitis&#x000a0;B vaccination.</article-title><source>J Infect</source>. <year>1991</year>;<volume>22</volume>(<issue>2</issue>):<fpage>191</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0163-4453(91)91723-B</pub-id><pub-id pub-id-type="pmid">2026895</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>Heng</surname>
<given-names>BH</given-names></string-name>, <string-name><surname>Goh</surname>
<given-names>KT</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chew</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Doraisingham</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Quek</surname>
<given-names>GH</given-names></string-name>. <article-title>Prevalence of hepatitis&#x000a0;B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity.</article-title><source>J Epidemiol Community Health</source>. <year>1995</year>;<volume>49</volume>(<issue>3</issue>):<fpage>309</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1136/jech.49.3.309</pub-id><pub-id pub-id-type="pmid">7629470</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>Villarejos</surname>
<given-names>VM</given-names></string-name>, <string-name><surname>Vison&#x000e1;</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Guti&#x000e9;rrez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez</surname>
<given-names>A</given-names></string-name>. <article-title>Role of saliva, urine and feces in the transmission of type B hepatitis.</article-title><source>N Engl J Med</source>. <year>1974</year>;<volume>291</volume>(<issue>26</issue>):<fpage>1375</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM197412262912602</pub-id><pub-id pub-id-type="pmid">4427641</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Ni</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>HY</given-names></string-name>, <etal>et al.</etal><article-title>Long-term follow-up of hepatitis&#x000a0;B surface antibody levels in subjects receiving universal hepatitis&#x000a0;B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.</article-title><source>Clin Diagn Lab Immunol</source>. <year>2005</year>;<volume>12</volume>(<issue>12</issue>):<fpage>1442</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">16339069</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>John</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Cooksley</surname>
<given-names>G</given-names></string-name>; <collab>Steering Committee for the Prevention and Control of Infectious Diseases in Asia</collab>. <article-title>Hepatitis&#x000a0;B vaccine boosters: is there a clinical need in high endemicity populations?</article-title><source>J Gastroenterol Hepatol</source>. <year>2005</year>;<volume>20</volume>(<issue>1</issue>):<fpage>5</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2004.03398.x</pub-id><pub-id pub-id-type="pmid">15610440</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>LY</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>HH</given-names></string-name>. <article-title>Ethnicity, substance use, and response to booster hepatitis&#x000a0;B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.</article-title><source>J Hepatol</source>. <year>2007</year>;<volume>46</volume>(<issue>6</issue>):<fpage>1018</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2007.01.022</pub-id><pub-id pub-id-type="pmid">17399842</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><string-name><surname>Ni</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>DS</given-names></string-name>. <article-title>Minimization of hepatitis&#x000a0;B infection by a 25-year universal vaccination program.</article-title><source>J Hepatol</source>. <year>2012</year>;<volume>57</volume>(<issue>4</issue>):<fpage>730</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2012.05.021</pub-id><pub-id pub-id-type="pmid">22668640</pub-id></mixed-citation></ref></ref-list></back></article>